FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, in particular to a formulation comprising an anti-IL-13 antibody, a surfactant and a histidine acetate buffer, for the treatment of allergic, autoimmune and inflammatory disease or disorders. Also disclosed is a kit comprising said formulation for treating a patient.
EFFECT: invention allows effectively treating allergic, autoimmune or inflammatory disease or disorder.
60 cl, 20 dwg, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS COMPRISING PURIFIED RECOMBINANT POLYPEPTIDES | 2014 |
|
RU2671481C2 |
| COMPOSITION CONTAINING ANTIBODY | 2019 |
|
RU2806628C2 |
| PHARMACEUTICAL FORMULATION CONTAINING ADVANCED ANTIBODY MOLECULES | 2010 |
|
RU2565809C2 |
| COMPOSITIONS BASED ON BISPECIFIC ANTIBODIES TO IL-4/IL-13 | 2014 |
|
RU2690850C2 |
| COMBINED FORMULATIONS OF ANTI-LAG3 ANTIBODY AND ANTI-PD-1 ANTIBODY | 2019 |
|
RU2822192C2 |
| HUMANISED ANTIBODIES WITH INCREASED STABILITY | 2015 |
|
RU2684703C2 |
| COMPOSITIONS OF ANTIBODIES TO RSV AND METHODS OF THEIR APPLICATION | 2019 |
|
RU2807524C2 |
| FORMULATIONS BASED ON CD19 ANTIBODY | 2017 |
|
RU2748024C2 |
| STABLE COMPOSITIONS OF ANTIBODIES AGAINST PROGRAMMABLE DEATH RECEPTOR OF PD-1 PERSON AND RELATED TREATMENT | 2012 |
|
RU2633509C2 |
| METHODS AND COMPOSITIONS INCLUDING PURIFIED RECOMBINANT POLYPEPTIDES | 2014 |
|
RU2793783C1 |
